Cargando…

Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites

BACKGROUND: Enteroendocrine cells are essential for the regulation of glucose metabolism, but it is unknown whether they are associated with clinical features of metabolic syndrome (MetS) and fasting plasma metabolites. OBJECTIVE: We aimed to identify fasting plasma metabolites that associate with d...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Baar, Annieke C G, Prodan, Andrei, Wahlgren, Camilla D, Poulsen, Steen S, Knop, Filip K, Groen, Albert K, Bergman, Jacques J, Nieuwdorp, Max, Levin, Evgeni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952241/ https://www.ncbi.nlm.nih.gov/pubmed/29669802 http://dx.doi.org/10.1530/EC-18-0094

Ejemplares similares

Does disease start in the mouth, the gut or both?
por: Prodan, Andrei, et al.
Publicado: (2019)

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?
por: van Baar, Annieke C G, et al.
Publicado: (2021)

A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study
por: Meiring, Suzanne, et al.
Publicado: (2022)

Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes
por: Meiring, Suzanne, et al.
Publicado: (2022)

Comparing bioinformatic pipelines for microbial 16S rRNA amplicon sequencing
por: Prodan, Andrei, et al.
Publicado: (2020)

Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study
por: Koopen, Annefleur, et al.
Publicado: (2022)

Correlation of plasma metabolites with glucose and lipid fluxes in human insulin resistance
por: Hartstra, Annick V., et al.
Publicado: (2020)

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study
por: van Baar, Annieke C G, et al.
Publicado: (2020)

Duodenal mucosal resurfacing: Multicenter experience implementing a minimally invasive endoscopic procedure for treatment of type 2 diabetes mellitus
por: van Baar, Annieke C.G., et al.
Publicado: (2020)

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020)

Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition
por: Koopen, Annefleur M., et al.
Publicado: (2020)

An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases
por: Groen, Albert K, et al.
Publicado: (2016)

Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results
por: van Baar, Annieke C.G., et al.
Publicado: (2019)

Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events
por: Meiring, S., et al.
Publicado: (2022)

Gut Microbiota in Hypertension and Atherosclerosis: A Review
por: Verhaar, Barbara J. H., et al.
Publicado: (2020)

Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome
por: Gilijamse, Pim W., et al.
Publicado: (2020)

Differential DNA methylation in familial hypercholesterolemia
por: Reeskamp, Laurens F., et al.
Publicado: (2020)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Statistical evaluation of diet-microbe associations
por: Zhang, Xiang, et al.
Publicado: (2019)

Gut Microbiota in Nutrition and Health with a Special Focus on Specific Bacterial Clusters
por: Bresser, Lucas R. F., et al.
Publicado: (2022)

Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD
por: Meijnikman, Abraham S., et al.
Publicado: (2021)

Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐N‐Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome
por: Smits, Loek P., et al.
Publicado: (2018)

Recent insights into the role of microbiome in the pathogenesis of obesity
por: van der Vossen, Eduard W. J., et al.
Publicado: (2022)

Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area
por: Balvers, Manon, et al.
Publicado: (2021)

Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome
por: Hartstra, Annick V., et al.
Publicado: (2020)

The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions
por: Zwartjes, Max S. Z., et al.
Publicado: (2021)

Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial
por: Mingrone, Geltrude, et al.
Publicado: (2022)

Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review
por: Hoozemans, Jacqueline, et al.
Publicado: (2021)

Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
por: Meijnikman, Abraham Stijn, et al.
Publicado: (2021)

Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease
por: Bom, Michiel J., et al.
Publicado: (2018)

Duodenal stents for malignant duodenal strictures.
por: Johnston, S. D., et al.
Publicado: (2002)

Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk
por: Warmbrunn, Moritz V., et al.
Publicado: (2021)

Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome
por: van der Vossen, Eduard W. J., et al.
Publicado: (2021)

Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
por: Stols-Gonçalves, Daniela, et al.
Publicado: (2019)

OR30-07 Mixed Meal Tolerance Test (MMTT) Results from Revita-2, the First Randomized, Sham-Controlled, Double-Blind, Prospective, Multicenter Study of Duodenal Mucosal Resurfacing (DMR) Safety and Efficacy in Patients with Sub-Optimally Controlled Type 2 Diabetes (T2D)
por: Hopkins, David, et al.
Publicado: (2020)

Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis
por: Dong, Tien S., et al.
Publicado: (2021)

Editorial: Proglucagon-Derived Peptides
por: Flatt, Peter R., et al.
Publicado: (2021)

Protein Phosphatase 1 Regulatory Subunit 3B Genotype at rs4240624 Has a Major Effect on Gallbladder Bile Composition
por: Männistö, Ville, et al.
Publicado: (2020)

Mapping prohormone processing by proteases in human enteroendocrine cells using genetically engineered organoid models
por: Beumer, Joep, et al.
Publicado: (2022)

A salivary metabolite signature that reflects gingival host-microbe interactions: instability predicts gingivitis susceptibility
por: Fernandez-Gutierrez, Marcela M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5mk3f8ge1gc03ne36gh2njaoe2